News | April 16, 2025
Nissan Chemical extends supply agreement with MSD Animal Health for Fluralaner
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
The product will be launched in Q1FY26
The supply of these goods is set to commence within the first quarter of FY26
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Subscribe To Our Newsletter & Stay Updated
